PEGylated Recombinant Factor VIII
- Generic Name
- PEGylated Recombinant Factor VIII
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1417412-83-9
- Unique Ingredient Identifier
- 5X3GF74R79
- Background
PEGylated Recombinant Factor VIII is under investigation in clinical trial NCT02585960 (BAX 855 Pk-guided Dosing).
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Takeda
- Target Recruit Count
- 37
- Registration Number
- NCT05707351
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, China
🇨🇳Beijing Children's Hospital, Capital Medical University, Beijing, China
🇨🇳Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Takeda
- Target Recruit Count
- 16
- Registration Number
- NCT04941898
- Locations
- 🇯🇵
Takeda Selected Site, Tokyo, Japan
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT04690322
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Baxalta now part of Shire
- Target Recruit Count
- 120
- Registration Number
- NCT02615691
- Locations
- 🇺🇸
Center for Advanced Pediatrics, Atlanta, Georgia, United States
🇲🇾Hospital Ampang, Ampang, Kuala Lumpur, Malaysia
🇨🇳Tri-Service General Hospital, Taipei City, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath